Skyline Diagnostics Preps Leukemia Test for US Launch; Gains CE-IVD Mark

Skyline has received $1.5 million from the Dutch government to support a clinical study of AMLprofiler that will generate data it can use when it seeks US Food and Drug Administration clearance for the test next year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.